Show simple item record

dc.contributor.authorAmanya, Ian
dc.date.accessioned2022-08-09T05:59:57Z
dc.date.available2022-08-09T05:59:57Z
dc.date.issued2022-08
dc.identifier.citationAmanya, I. (2022). Isoniazid preventive therapy completion and factors associated with non-completion among patients on antiretroviral therapy at Kisenyi Health Centre IV, Kampala, Uganda. (Unpublished Master's Dissertation). Makerere University, Kampala, Uganda.en_US
dc.identifier.urihttp://hdl.handle.net/10570/10730
dc.descriptionA dissertation submitted to the Directorate of Research and Graduate Training in partial fulfilment of the requirements for the award of the degree of Master of Health Services Research of Makerere University.en_US
dc.description.abstractIntroduction: Isoniazid preventive therapy is given to people living with HIV to reduce the risk of active tuberculosis. However, treatment completion remains sub-optimal among those that are initiated. This study aimed to determine the completion level of IPT and the factors associated with non-completion among people on antiretroviral therapy at Kisenyi Health Center IV in Kampala, Uganda. Methods: A facility-based retrospective cohort study utilizing routinely collected data of 341 randomly selected HIV patients initiated on IPT was conducted. Data extracted from the registers were used to determine the completion of IPT. Modified Poisson regression with robust error variances was used to determine the associated factors of non-completion while In-depth interviews were conducted to explore barriers to IPT completion from the patient’s perspective. Results: A total of 341 patients who started on INH were retrospectively followed up, with 69% (236/341) being female. Overall IPT completion was at 83%. Multivariable analysis revealed the prevalence of non-completion among males was 2.24 times the prevalence among females [aPR 2.24, 95% CI: 1.40-3.58]. The prevalence of non-completion among patients with a non-suppressed HIV viral load was 3.00 times the prevalence among those with a suppressed HIV viral load [aPR 3.00, 95% CI: 1.44-6.65]. Patients who were married/living with a partner had a 69% lower prevalence of IPT non-completion compared to those who were single [aPR 0.31, 95% CI: 0.17-0.55]. Lack of IPT-related health education, pill burden, distance to the health facility, and patient relocation were reported as the barriers to IPT completion. Conclusion: IPT completion was found to be at 83% among the cohort studied. However, lower completion levels persist among males and patients with unsuppressed HIV viral load. Lack of IPT-related health education, pill burden, distance to the health facility, and patient relocation were reported as the barriers to IPT completion. Interventions that target these groups of people need to be developed and intensified.en_US
dc.language.isoenen_US
dc.publisherMakerere Universityen_US
dc.subjectIPTen_US
dc.subjectINHen_US
dc.subjectTB Preventionen_US
dc.subjectHIV/AIDSen_US
dc.subjectARTen_US
dc.subjectIsoniazid preventive therapyen_US
dc.subjectpatientsen_US
dc.subjectantiretroviral therapyen_US
dc.subjectKisenyi Health Centre IVen_US
dc.subjectKampalaen_US
dc.subjectUgandaen_US
dc.titleIsoniazid preventive therapy completion and factors associated with non-completion among patients on antiretroviral therapy at Kisenyi Health Centre IV, Kampala, Ugandaen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record